Literature DB >> 19568694

Inner blood-retinal barrier transporters: role of retinal drug delivery.

Ken-ichi Hosoya1, Masanori Tachikawa.   

Abstract

The inner blood-retinal barrier (inner BRB) forms complex tight junctions of retinal capillary endothelial cells to prevent the free diffusion of substances between the circulating blood and the neural retina. Thus, understanding of the inner BRB transport mechanisms could provide a basis for the development of strategies for drug delivery to the retina. Recent progress in inner BRB research has revealed that retinal endothelial cells express a variety of unique transporters which play a role in the influx transport of essential molecules and the efflux transport of xenobiotics. In this review we focus on the transport mechanism at the inner BRB in relation to its importance in influencing the inner BRB permeability of drugs.

Mesh:

Substances:

Year:  2009        PMID: 19568694     DOI: 10.1007/s11095-009-9930-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  103 in total

Review 1.  Vitamin E: antioxidant activity, biokinetics, and bioavailability.

Authors:  G W Burton; M G Traber
Journal:  Annu Rev Nutr       Date:  1990       Impact factor: 11.848

2.  Characteristics of choline transport across the blood-brain barrier in mice: correlation with in vitro data.

Authors:  H Murakami; N Sawada; N Koyabu; H Ohtani; Y Sawada
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

Review 3.  The purine nucleoside adenosine in retinal ischemia-reperfusion injury.

Authors:  G J Ghiardi; J M Gidday; S Roth
Journal:  Vision Res       Date:  1999-07       Impact factor: 1.886

4.  Function and regulation of taurine transport at the inner blood-retinal barrier.

Authors:  Masatoshi Tomi; Tomoyuki Terayama; Tomoyuki Isobe; Fuminobu Egami; Akihisa Morito; Michio Kurachi; Sumio Ohtsuki; Young-Sook Kang; Tetsuya Terasaki; Ken-ichi Hosoya
Journal:  Microvasc Res       Date:  2006-11-28       Impact factor: 3.514

5.  Folate and 10-formyltetrahydrofolate dehydrogenase in human and rat retina: relation to methanol toxicity.

Authors:  M K Martinasevic; M D Green; J Baron; T R Tephly
Journal:  Toxicol Appl Pharmacol       Date:  1996-12       Impact factor: 4.219

6.  Lactate transport through the blood-retinal and the blood-brain barrier in rats.

Authors:  A Alm; P Törnquist
Journal:  Ophthalmic Res       Date:  1985       Impact factor: 2.892

7.  Involvement of reduced folate carrier 1 in the inner blood-retinal barrier transport of methyltetrahydrofolate.

Authors:  Ken-ichi Hosoya; Keiko Fujita; Masanori Tachikawa
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

8.  Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine.

Authors:  Ken-ichi Hosoya; Akihide Makihara; Yuki Tsujikawa; Daisuke Yoneyama; Shinobu Mori; Tetsuya Terasaki; Shin-ichi Akanuma; Masatoshi Tomi; Masanori Tachikawa
Journal:  J Pharmacol Exp Ther       Date:  2008-12-30       Impact factor: 4.030

9.  Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.

Authors:  M Friedlander; C L Theesfeld; M Sugita; M Fruttiger; M A Thomas; S Chang; D A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina.

Authors:  C L Poitry-Yamate; S Poitry; M Tsacopoulos
Journal:  J Neurosci       Date:  1995-07       Impact factor: 6.167

View more
  24 in total

Review 1.  [Special hematological diagnostics and therapy options for ocular lymphoma taking CNS involvement into account].

Authors:  A Korfel; U Schlegel; R Schroers
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

Review 2.  Physiologic and anatomic characterization of the brain surface glia barrier of Drosophila.

Authors:  Michael K DeSalvo; Nasima Mayer; Fahima Mayer; Roland J Bainton
Journal:  Glia       Date:  2011-02-23       Impact factor: 7.452

Review 3.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

4.  Retinal transfer of nicotinate by H+ -monocarboxylate transporter at the inner blood-retinal barrier.

Authors:  Masanori Tachikawa; Koji Murakami; Pamela M Martin; Ken-ichi Hosoya; Vadivel Ganapathy
Journal:  Microvasc Res       Date:  2011-06-29       Impact factor: 3.514

5.  Retinal phagocytes in age-related macular degeneration.

Authors:  Soo-Young Kim
Journal:  Macrophage (Houst)       Date:  2015

6.  Extended release of dexamethasone from oleogel based rods.

Authors:  Russell Macoon; Timothy Guerriero; Anuj Chauhan
Journal:  J Colloid Interface Sci       Date:  2019-07-31       Impact factor: 8.128

Review 7.  Nanotechnology in retinal drug delivery.

Authors:  Sibo Jiang; Yesenia L Franco; Yan Zhou; Jianjun Chen
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

8.  Lipophilicity and transporter influence on blood-retinal barrier permeability: a comparison with blood-brain barrier permeability.

Authors:  Ken-ichi Hosoya; Atsushi Yamamoto; Shin-ichi Akanuma; Masanori Tachikawa
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

9.  Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat.

Authors:  Annette E Allen; Elizabeth A Martin; Katherine Greenwood; Claire Grant; Peter Vince; Robert J Lucas; William S Redfern
Journal:  Br J Pharmacol       Date:  2020-09-13       Impact factor: 8.739

10.  Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.

Authors:  Francesco Pichi; Paolo Nucci; Kimberly Baynes; Careen Y Lowder; Sunil K Srivastava
Journal:  Int Ophthalmol       Date:  2016-05-24       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.